Health Enhancement Products Inc. in conjunction with Wayne State University and the WSU research team, led by Smiti Gupta, Ph.D., assistant professor of nutrition & food sciences in the College of Liberal Arts and Sciences, have issued a positive preliminary report on lipid oxidation (oxidative stress) using HEPI's ProAlgaZyme (PAZ) filtrates. Oxidative stress is defined as the tissue damage resulting from the imbalance between an excessive generation of oxidant compounds and antioxidant defense mechanisms. It is widely recognized that the generation of oxidative compounds is an important mechanism of normal physiology, playing a role in both inflammation and tissue repair processes. Oxidative stress represents part of the defense mechanisms against invading micro-organisms and malignant cells, as well as a signal for tissue healing and remodeling. The test results show a statistically significant (p less than 0.050) decrease in plasma lipid peroxidation value of 9.6 nMol/ml for a group of animals drinking PAZ filtrates compared to 13.0 nMol/ml for a control group which was administered pure drinking water, a 26.1% decrease. The results are part of the long-term study being conducted by Dr. Gupta's research team based at WSU. These results follow the Company's July 15, 2009 announcement disclosing preliminary test results which indicated that the PAZ organic compound reduced LDL cholesterol levels from 132 mg/dL to 80 mg/dL and improved HDL cholesterol from 105 mg/dL to 139 mg/dL in test animal subjects.

Health Enhancement Products Inc. (HEPI) and Changing Times Vitamins Inc. have mutually agreed to terminate their current distribution agreement, in which Changing Times Vitamins had acquired the exclusive rights to distribute ProAlgaZyme (PAZ). Under terms of the definitive agreement, HEPI retains all marketing and sales rights associated with the Company's proprietary ProAlgaZyme(TM) (PAZ) compound. HEPI will also retain control of all remaining inventory, labels, bottles, promotional materials, as well as customer contact information.

On September 8, 2009, Health Enhancement Products Inc. announced Peter Vitulli was appointed interim CEO of the company and its parent company. Mr. Vitulli is expected to serve as interim CEO for up to three months. The company and Mr. Vitulli may agree to extend Mr. Vitulli's term as CEO beyond the initial three month period. Mr. Vitulli and HEPI each have the right to terminate the employment relationship upon thirty days notice. HEPI and Mr. Vitulli may agree to extend Mr. Vitulli's term as CEO. Since July, 2006, Mr. Vitulli has been President and CEO of Sconia, Inc., a venture capital backed genetics-based health and wellness company. Mr. Vitulli has also served as chairman of the Board of Efficas, Inc, since November, 2006. From 1998 until April, 2005, Mr. Vitulli served as president and CEO of Amerifit Nutrition, Inc..